Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22608338 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors
Condition: Cancer
Interventions: Drug: GSK2118436;   Drug: Midazolam

Study has passed its completion date and status has not been verified in more than two years.